AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,498 | -66,045 | -46,124 | -24,308 | -7,950 |
| Depreciation Amortization | 606 | 2,098 | 1,577 | 985 | 381 |
| Accounts payable and accrued liabilities | -1,988 | 2,322 | 1,025 | 1,408 | 662 |
| Other Working Capital | -1,695 | -4,878 | -3,479 | -4,778 | -4,105 |
| Other Operating Activity | 2,408 | 3,022 | 3,343 | 1,210 | 997 |
| Operating Cash Flow | $-19,167 | $-63,481 | $-43,659 | $-25,483 | $-10,016 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 31,998 | 27,183 | 10,377 | N/A |
| PPE Investments | -873 | -1,751 | -910 | -609 | -219 |
| Other Investing Activity | 0 | -31 | 0 | 0 | 0 |
| Investing Cash Flow | $-873 | $30,216 | $26,272 | $9,768 | $-219 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8,777 | 259 | 264 | N/A | -4 |
| Common Stock Repurchased | N/A | -107 | N/A | N/A | N/A |
| Other Financing Activity | -258 | -1,009 | -637 | -499 | -383 |
| Financing Cash Flow | $8,519 | $-857 | $-373 | $-499 | $-387 |
| Exchange Rate Effect | 687 | -750 | -746 | -517 | -469 |
| Beginning Cash Position | 177,851 | 206,480 | 210,487 | 200,885 | 200,169 |
| End Cash Position | 167,017 | 171,609 | 191,981 | 184,154 | 189,077 |
| Net Cash Flow | $-10,834 | $-34,871 | $-18,506 | $-16,731 | $-11,092 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,167 | -63,481 | -43,659 | -25,483 | -10,016 |
| Capital Expenditure | -873 | -1,820 | -910 | -609 | -219 |
| Free Cash Flow | -20,040 | -65,300 | -44,570 | -26,092 | -10,236 |